Swing publishes Phase III data for fibromyalgia digital therapy
The data from the Phase III study showed the efficacy of Swing’s smartphone-based behavioural therapy, Stanza, in improving fibromyalgia symptoms.
Digital Therapeutics
Click Therapeutics acquires assets from Better Therapeutics
Innovate UK funds digital health compliance platform
Innosphere starts paediatric clinical trial for Novostim ADHD device
Curio wins FDA approval for its postpartum depression digital therapeutic
Akili prepares for Japan launch of ADHD gaming therapy
US digital therapeutics market to grow at 25% CAGR from 2022 to 2030
Can Elon Musk’s Neuralink be trusted to put chips in your brain?
